LTIP265A - Blood coagulation factor xi concentrate and process for the preparing same - Google Patents
Blood coagulation factor xi concentrate and process for the preparing sameInfo
- Publication number
- LTIP265A LTIP265A LTIP265A LTIP265A LTIP265A LT IP265 A LTIP265 A LT IP265A LT IP265 A LTIP265 A LT IP265A LT IP265 A LTIP265 A LT IP265A LT IP265 A LTIP265 A LT IP265A
- Authority
- LT
- Lithuania
- Prior art keywords
- concentrate
- blood coagulation
- coagulation factor
- preparing same
- factor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6443—Coagulation factor XIa (3.4.21.27)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21027—Coagulation factor XIa (3.4.21.27)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention relates to a human Factor XI concentrate having high specific activity prepared using a process comprising a filtration-adsorption step and a single step of chromatography on cation exchange resin. The concentrate obtained is perfectly suitable for therapeutic use in replacement therapy in cases of Factor XI deficiency.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9105572A FR2676231A1 (en) | 1991-05-07 | 1991-05-07 | BLOOD COAGULATION FACTOR XI CONCENTRATE WITH HIGH SPECIFIC ACTIVITY, SUITABLE FOR THERAPEUTIC USE AND ITS PREPARATION PROCESS. |
Publications (2)
Publication Number | Publication Date |
---|---|
LTIP265A true LTIP265A (en) | 1994-10-25 |
LT3417B LT3417B (en) | 1995-09-25 |
Family
ID=9412593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTIP265A LT3417B (en) | 1991-05-07 | 1992-12-29 | Blood coagulation factor xi concentrate and process for the preparing same |
Country Status (16)
Country | Link |
---|---|
US (1) | US5252217A (en) |
EP (1) | EP0512883B1 (en) |
AT (1) | ATE156360T1 (en) |
AU (1) | AU652043B2 (en) |
BR (1) | BR9201718A (en) |
CA (1) | CA2068069C (en) |
DE (1) | DE69221369T2 (en) |
DK (1) | DK0512883T3 (en) |
EE (1) | EE03017B1 (en) |
ES (1) | ES2107511T3 (en) |
FR (1) | FR2676231A1 (en) |
GR (1) | GR3025134T3 (en) |
IL (1) | IL99567A (en) |
LT (1) | LT3417B (en) |
RU (1) | RU2097047C1 (en) |
UA (1) | UA27733C2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030040480A1 (en) * | 2001-07-20 | 2003-02-27 | Rasmus Rojkjaer | Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides |
WO2003007983A1 (en) * | 2001-07-20 | 2003-01-30 | Novo Nordisk Health Care Ag | Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides |
US20050181978A1 (en) * | 2003-11-20 | 2005-08-18 | Rasmus Rojkjaer | Therapeutic use of factor XI |
CA2540986A1 (en) * | 2003-11-20 | 2005-06-02 | Novo Nordisk Health Care Ag | Therapeutic use of factor xi |
WO2006128497A1 (en) * | 2005-06-01 | 2006-12-07 | Novo Nordisk A/S | Pharmaceutical formulation of factor xi |
WO2008031020A2 (en) * | 2006-09-08 | 2008-03-13 | Wyeth | Arginine wash in protein purification using affinity chromatography |
WO2008081025A1 (en) * | 2007-01-04 | 2008-07-10 | Crucell Holland B.V. | Purification of factor xi |
EP3335715A3 (en) * | 2008-10-15 | 2018-08-08 | Ionis Pharmaceuticals, Inc. | Modulation of factor 11 expression |
FR2974366B1 (en) * | 2011-04-20 | 2016-06-24 | Lab Francais Du Fractionnement | PROCESS FOR PREPARING A FACTOR XI CONCENTRATE |
FR2974301B1 (en) | 2011-04-20 | 2013-08-23 | Lab Francais Du Fractionnement | PROCESS FOR THE PREPARATION OF A PLASMATIC PRODUCT DEPLETE IN ONE OR MORE THROMBOGENIC FACTORS |
IL212911A0 (en) | 2011-05-16 | 2011-07-31 | Omrix Biopharmaceuticals Ltd | Immunoglobulin reduced in thrombogenic contaminants and preparation thereof |
DE102012022234A1 (en) | 2012-11-14 | 2014-05-15 | Instraction Gmbh | One step process for purifying (blood) plasma proteins, such as albumin from mixtures |
DE102012022233A1 (en) | 2012-11-14 | 2014-05-15 | Instraction Gmbh | Process for purifying a (blood) plasma protein |
FR3032621A1 (en) | 2015-02-13 | 2016-08-19 | Lab Francais Du Fractionnement | BIOLOGICAL GLUE AND ITS USE AS MEDICINE |
KR101941974B1 (en) * | 2016-11-18 | 2019-01-24 | 주식회사 녹십자 | Methods for Eliminating Factor XI during Plasma Protein Purification |
MX2020011913A (en) | 2018-05-09 | 2021-01-29 | Ionis Pharmaceuticals Inc | Compounds and methods for reducing fxi expression. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4859340A (en) * | 1976-03-15 | 1989-08-22 | Cuno, Incorporated | Filter sheet |
US4783262A (en) * | 1987-03-30 | 1988-11-08 | Cuno Incorporated | Separator for cell type filter element |
-
1991
- 1991-05-07 FR FR9105572A patent/FR2676231A1/en active Granted
- 1991-09-25 IL IL9956791A patent/IL99567A/en not_active IP Right Cessation
-
1992
- 1992-04-23 DK DK92401157.0T patent/DK0512883T3/en active
- 1992-04-23 ES ES92401157T patent/ES2107511T3/en not_active Expired - Lifetime
- 1992-04-23 EP EP92401157A patent/EP0512883B1/en not_active Expired - Lifetime
- 1992-04-23 AT AT92401157T patent/ATE156360T1/en active
- 1992-04-23 DE DE69221369T patent/DE69221369T2/en not_active Expired - Lifetime
- 1992-04-29 AU AU15263/92A patent/AU652043B2/en not_active Expired
- 1992-05-06 RU SU925011788A patent/RU2097047C1/en active
- 1992-05-06 CA CA002068069A patent/CA2068069C/en not_active Expired - Lifetime
- 1992-05-07 BR BR929201718A patent/BR9201718A/en not_active Application Discontinuation
- 1992-05-07 US US07/879,273 patent/US5252217A/en not_active Expired - Lifetime
- 1992-12-29 LT LTIP265A patent/LT3417B/en not_active IP Right Cessation
-
1993
- 1993-05-21 UA UA93002714A patent/UA27733C2/en unknown
-
1994
- 1994-05-23 EE EE9400003A patent/EE03017B1/en not_active IP Right Cessation
-
1997
- 1997-10-22 GR GR970402766T patent/GR3025134T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
US5252217A (en) | 1993-10-12 |
RU2097047C1 (en) | 1997-11-27 |
CA2068069C (en) | 2005-03-15 |
EP0512883B1 (en) | 1997-08-06 |
AU1526392A (en) | 1992-11-12 |
EE03017B1 (en) | 1997-08-15 |
DK0512883T3 (en) | 1998-03-16 |
CA2068069A1 (en) | 1992-11-08 |
ES2107511T3 (en) | 1997-12-01 |
DE69221369T2 (en) | 1998-03-19 |
ATE156360T1 (en) | 1997-08-15 |
FR2676231A1 (en) | 1992-11-13 |
EP0512883A1 (en) | 1992-11-11 |
LT3417B (en) | 1995-09-25 |
UA27733C2 (en) | 2000-10-16 |
GR3025134T3 (en) | 1998-02-27 |
FR2676231B1 (en) | 1995-04-21 |
IL99567A (en) | 1996-01-19 |
DE69221369D1 (en) | 1997-09-11 |
IL99567A0 (en) | 1992-08-18 |
BR9201718A (en) | 1992-12-29 |
AU652043B2 (en) | 1994-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTIP265A (en) | Blood coagulation factor xi concentrate and process for the preparing same | |
GR3024263T3 (en) | Methods and deoxyribonucleic acid for the preparation of tissue factor protein | |
AU582972B2 (en) | Lipoprotein adsorbent for use in extracorporeal circulation treatment and process for preparing thereof | |
AU7426487A (en) | Method of treating depression using d-fenfluramine | |
AU5413490A (en) | Photochemical treatment of blood vessels | |
AU584548B2 (en) | Sterilization of adsorbent and column having improved storability including sterilized adsorbent for use in extracorporeal circulation treatment | |
DE3572441D1 (en) | Use of interferon gamma (ifn-gamma) for the production of preparations for treating rheumatic diseases | |
EP0212310A3 (en) | Use of probucol in the preparation of a medicament for the treatment of heart arrhythmia | |
GR3018365T3 (en) | Use of 15-deoxyspergualine as a medicament. | |
ZA86101B (en) | Process for recovering absorbent for use in extracorporeal circulation treatment | |
PL277464A1 (en) | Apparatus for surgical treatment of ametropia | |
HU900381D0 (en) | Process for producing medical preparatives utilizable for treating cancerous diseases | |
EP0144489A3 (en) | Cerebral and peripheral antihypoxidoticum | |
ZA881828B (en) | Preparation for treatment of skin disorders | |
ZA858104B (en) | Sterilization of adsorbent and column having improved storability including sterilized adsorbent for use in extracorporeal circulation treatment | |
GB8817446D0 (en) | Treatment of various blood disorders | |
AU1071888A (en) | Pharmaceutical preparation for treatment of hyperacidity in body fluids | |
GR3005378T3 (en) | ||
IL80118A0 (en) | Apparatus for use in surgery of human body | |
AU99667S (en) | Physical therapy treatment table | |
IE871907L (en) | "methods for treatment of sundamaged human skin with¹retinoids" | |
GB8825464D0 (en) | Electro therapy chair for treatment of various dermatological & rheumatological diseases | |
ZA858102B (en) | Lipoprotein adsorbent for use in extracorporeal circulation treatment and process for preparing thereof | |
PL271057A1 (en) | Method of making therapeutic cream for treatment of dermatopathies, in particular burns | |
IL125789A (en) | USE OF A DELETION VARIANT HUMAN t-PA PROTEIN IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF VASCULAR DISEASES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC9A | Transfer of patents |
Owner name: THE LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES Effective date: 20090511 |
|
TC9A | Change of representative |
Representative=s name: ZABOLIENE, REDA, LT |
|
MM9A | Lapsed patents |
Effective date: 20091229 |